Our leadership team at Cyclo brings deep and diverse experience across research, drug development, and commercialization, with a particular expertise in rare diseases and underserved patient communities. Our team brings scientific and operational expertise, and a clear understanding of the unique challenges faced by underserved patient populations. Guided by our commitment to act in the best interest of the communities we serve, we prioritize patient needs at every stage—from research and clinical development to access and delivery—working to transform the lives of patients and families around the world.